一、項目名稱：原料藥及醫藥中間體生產加工項目
二、項目背景
清浦區西安路工業園，緊靠淮安市老工業基地，規劃面積10平方公里，目前已建成5平方公里，水、電、路、氣、訊配套齊全。醫藥產業是園區的四大主導產業之一，已入住的江蘇天士力帝益藥業有限公司由天士力集團投資建設，占地200畝，是集研發、生產、營銷整條產業鏈高科技制藥企業。年產變性淀粉5萬噸、肝泰樂600萬噸，是全球最大的肝泰樂生產基地。浙江臺州投資興建的誠意藥業醫藥中間體項目年產值億元以上，歡迎有識之士來我區投資興建醫藥加工項目。
三、建設內容：原料藥及醫藥中間體
四、投資規模：1億元以上
五、建設地點：清浦工業新區
六、項目提出單位：清浦工業園
29.Active Pharmaceutical Ingredient (API) and Pharmaceutical Intermediates Producing and Processing Project
1.Project name：Active Pharmaceutical Ingredient (API) and Pharmaceutical Intermediates Producing and Processing Project
2. Project background
Xi’an Road Industry Park in Qingpu District, 10 square kilometers in area for investment,is close to Huaian city’s old industrial base. At present, 5 square kilometers of the industrial zone has been finished with supporting system like water, electricity, traffic, gas, communication devices. Pharmaceutical industry is one of the four dominant industries in the park. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., as the company in the park, is invested by Tasly Group and occupies 200 mu in area. It is a high-tech pharmaceutical enterprise undertaking medicine research, manufacturing and marketing with an annual output of 50 thousand tons of Modified Starch and six million tons of Glucurolactone. It is the biggest production base of Glucurolactone in the world. The pharmaceutical intermediates project of Jiangsu Chengyi Pharmaceutical Co., invested by Taizhou capital of Zhejiang province, can get an annual output value of RMB 100 million or more. Welcome to invest pharmaceutical processing items in the Park.
3. Project content:Active Pharmaceutical Ingredient (API) and Pharmaceutical Intermediates
4. Investment scale:RMB 100 million or more
5. Construction location:Qingpu New Industry Zone
6. Project presenter:Qingpu Industry Park
- 項目對接快訊
-
- 最新信息
- 熱門信息
